Safapoor S

Title : Rhodanine-pyridinium derivatives as a new category of cholinesterase inhibitors: Design, synthesis, in vitro and in silico enzymatic evaluations - Noori_2025_Int.J.Biol.Macromol__145731

Author(s) : Noori M , Karimian S , Dastyafteh N , Ghafouri SN , Mohammadi-Khanaposhtani M , Safapoor S , Ghomi MK , Rastegar H , Saeedi S , Larijani B , Mahdavi M , Aktas A , Taslimi P , Gulcin I

Ref : Int J Biol Macromol , :145731 , 2025

Abstract :

PubMedSearch : Noori_2025_Int.J.Biol.Macromol__145731

PubMedID: 40617434

Title : Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392

Author(s) : Noori M , Dastyafteh N , Safapoor S , Ghomi MK , Tanideh R , Zomorian K , Hamedifar H , Dara M , Zare S , Irajie C , Javanshir S , Rastegar H , Panahi N , Larijani B , Mahdavi M , Hajimiri MH , Iraji A

Ref : Int J Biol Macromol , :127392 , 2023

Abstract :

PubMedSearch : Noori_2023_Int.J.Biol.Macromol__127392

PubMedID: 37827412

Safapoor S

References (2)

1. Rhodanine-pyridinium derivatives as a new category of cholinesterase inhibitors: Design, synthesis, in vitro and in silico enzymatic evaluations - Noori_2025_Int.J.Biol.Macromol__145731

2. Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392